Goldman Sachs
LSTA icon

Goldman Sachs’s Lisata Therapeutics LSTA Stock Holding History

Goldman Sachs’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,592
Closed -$87K – 6392
2021
Q2 		$87K Buy
+3,592
New +$85.1K ﹤0.01% 5971
2017
Q1 		– Sell
-741
Closed -$31K – 6904
2016
Q4 		$31K Buy
+741
New +$42.6K ﹤0.01% 6526
2016
Q3 		– Sell
-275
Closed -$24K – 7108
2016
Q2 		$24K Buy
275
+73
+36% +$6.71K ﹤0.01% 6658
2016
Q1 		$23K Sell
202
-1
-0.5% -$98 ﹤0.01% 6709
2015
Q4 		$33K Sell
203
-45
-18% -$8.26K ﹤0.01% 6718
2015
Q3 		$55K Sell
248
-485
-66% -$122K ﹤0.01% 6753
2015
Q2 		$206K Buy
733
+505
+221% +$188K ﹤0.01% 6126
2015
Q1 		$87K Buy
228
+161
+240% +$87.3K ﹤0.01% 6487
2014
Q4 		$38K Sell
67
-380
-85% -$259K ﹤0.01% 6879
2014
Q3 		$371K Buy
447
+23
+5% +$20.1K ﹤0.01% 5559
2014
Q2 		$414K Buy
424
+205
+94% +$199K ﹤0.01% 5488
2014
Q1 		$231K Buy
219
+23
+12% +$24.9K ﹤0.01% 5957
2013
Q4 		$201K Buy
+196
New +$194K ﹤0.01% 5959

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Goldman Sachs's LSTA Position: Q3 2021 in Review

Goldman Sachs sold out of Lisata Therapeutics (LSTA) in Q3 2021, closing a stake of 3,592 shares — an estimated $87K sold.

Goldman Sachs first reported a position in LSTA in Q4 2013 and held it in 13 quarters. The position peaked at $414K in Q2 2014. 32 funds tracked by Wall St. Rank hold LSTA as of Q3 2021.

  • Goldman Sachs reported no remaining Lisata Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 3,592 Lisata Therapeutics shares in Q3 2021, an estimated $87K.
  • Goldman Sachs first reported a position in Lisata Therapeutics in Q4 2013 and held it in 13 quarters.
  • Goldman Sachs's Lisata Therapeutics position peaked at $414K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.